Identity on this record
Material type: Dual-heptapeptide research blend.
Components: Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro) + Semax (Met-Glu-His-Phe-Pro-Gly-Pro).
CAS number: Not applicable — two-component blend.
Semax component CAS: 80714-61-0 (registry entry).
Appearance: White lyophilised blend.
Catalog strength: 10 mg blend vial.
Those identifiers describe Selank + Semax as a substance. They do not describe a particular vial. The vial is identified by the name, the nominal fill, and the lot number on its label, checked against the published certificate.
What the catalogue actually sells
Selank + Semax 10mg Blend is the 10 mg blend lyophilized unit, listed at AED 399 before VAT. The product record stores that sealed unit at 2–8 °C · protect from light.
Prices are merchandise prices in AED, exclusive of VAT. VAT is added at checkout. A price on this summary is the figure on the product record for Selank + Semax, not a delivered-cost quote.
Lots and certificates
Lot VL-SELSEMAX-20260917 is the catalogue certificate for Selank + Semax 10mg Blend. Read it on Selank + Semax 10mg Blend certificate and match the vial in batch verification. A certificate for a different strength, or for a blend that merely contains the same name, does not release this unit.
How the compound record describes the literature
Selank and Semax appear separately in Russian regulatory-peptide literature. A 2001 serum-enzyme paper names both. The catalog blend is a supply presentation, not a studied clinical combination.
Topics named on the Selank + Semax record, as literature context rather than as outcomes VaultLabs claims: Two-component identity and ratio verification; Blend vs single-SKU Semax documentation; Heptapeptide HPLC resolution.
That is context for identifying Selank + Semax. It is not a claim that a vial produces a result in a person, an animal, or a study VaultLabs has not published. VaultLabs does not provide dosage, administration, study-design, or medical guidance.
Points the monograph already states
Points already written on the Selank + Semax monograph, so a reader can check them against that page:
Two sequences, one vial: Selank (TKPRPGP) and Semax (MEHFPGP). There is no single molecular formula for the blend.
No CAS registry number applies to the combination. Publishing one would misrepresent the material.
Standalone Semax 10 mg and standalone Selank 10 mg are different lot families. A single-sequence certificate does not release this blend.
Both components are heptapeptides from the Russian regulatory-peptide literature, studied separately more often than together.
Catalog presentation is a 10 mg lyophilised blend (VL-SEL-SEMAX-10). Component milligram split is not published as a single-substance specification.
Not an approved medicine. Research-use only.
Dispatch and the research-use boundary
VaultLabs dispatches Selank + Semax from Dubai. Orders leave fulfillment within 24 hours, 7 days a week. Standard delivery is AED 35 to every emirate, and delivery is free when the post-discount merchandise subtotal is AED 500 or more. Checkout shows the fee for the address entered. All VaultLabs products are supplied strictly for laboratory and research use only. They are not intended for human consumption, medical use, personal use, or diagnostic use. VaultLabs does not provide dosage, administration, study-design, or medical guidance.
The full narrative record is the Selank + Semax compound monograph. Handling of the sealed unit is the Selank + Semax storage guide. Questions are collected on the Selank + Semax FAQ. How it differs from neighbouring records is the Selank + Semax comparison.